Holen Sie sich die Stockscreener-App
92.21
1.22%
-1.14
Handel nachbörslich:
92.25
0.04
+0.04%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$93.35
Offen:
$93.67
24-Stunden-Volumen:
8.24M
Relative Volume:
1.28
Marktkapitalisierung:
$118.24B
Einnahmen:
$33.20B
Nettoeinkommen (Verlust:
$4.26B
KGV:
28.03
EPS:
3.29
Netto-Cashflow:
$5.47B
1W Leistung:
-1.15%
1M Leistung:
+7.13%
6M Leistung:
+4.63%
1J Leistung:
+10.22%
1-Tages-Spanne:
$91.74
$93.72
1-Wochen-Bereich:
$90.35
$93.72
52-Wochen-Spanne:
$75.96
$96.25
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Vergleichen Sie MDT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
92.21 | 118.24B | 33.20B | 4.26B | 5.47B | 3.29 |
|
ABT
Abbott Laboratories
|
126.30 | 219.05B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
99.22 | 146.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
375.91 | 143.44B | 22.60B | 2.99B | 3.49B | 7.76 |
|
EW
Edwards Lifesciences Corp
|
70.34 | 41.35B | 5.72B | 4.17B | 259.90M | 6.97 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Medtronic stock slips after product recall (MDT:NYSE) - Seeking Alpha
Medtronic recalls embolization device after reported deaths - Mass Device
FDA classifies recall of Medtronic embolization devices as 'most serious' - Reuters
FDA Says Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device With Shield Technology - Marketscreener.com
FDA classifies recall of Medtronic embolization devices as 'most serious' -March 18, 2025 at 02:13 pm EDT - Marketscreener.com
Why Medtronic (MDT) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Medtronic plc (MDT): Among the Best European Stocks to Buy According to Billionaires - Yahoo Canada Finance
Medtronic (MDT) Announces Transition of Principal Accounting Off - GuruFocus.com
Medtronic Announces Leadership Transition in Finance Department - TipRanks
Lancet Market Projected to Reach USD 3.72 Billion by 2032, Growing at a 10.63% CAGR – SNS Insider - GlobeNewswire Inc.
The Zacks Analyst Blog Highlights NVIDIA, Resmed, GE HealthCare And Medtronic - Barchart
Medtronic’s SWOT analysis: stock poised for growth amid challenges - Investing.com
Electrophysiology Market to Reach $22.65 Bn, Globally, by 2030 at 14.4% CAGR | BOSTON SCIENTIFIC CORPORATION, - EIN News
Medtronic Seeks to Bolster Moat With Novel Cardiovascular Therapies - Morningstar
Medtronic Named One of the 2025 World’s Most Ethical Companies for the Third Time by Ethisphere - ACCESS Newswire
SCAAR data Prevails for Medtronic paclitaxel-coated balloon - BioWorld Online
nVent Electric taps Medtronic's Gary Corona as CFO - MSN
nVent Electric taps Medtronic's Gary Corona as CFO (NVT:NYSE) - Seeking Alpha
ECG Cable and ECG Lead Wires Market Set to Witness Significant Growth by 2025-2032: 3M Company, Medtronic plc, - EIN News
Data supports Medtronic Prevail paclitaxel-coated balloon - Mass Device
Medtronic Compliance Officer's Journey To State Senate Seat - Law360
Medtronic Presents New Data, Clinical Milestones at CRT 2025 - Diagnostic and Interventional Cardiology
Medtronic Presents New Data, Clinical Milestones - Diagnostic and Interventional Cardiology
Medtronic sees SMART TAVR results in small aortic annulus patients - BioWorld Online
Electroceutical Devices Market Projected To Witness Substantial Growth, 2025-2032: Medtronic plc, Abbott - EIN News
Endoscopes Market Projected To Witness Substantial Growth, 2025-2032: Medtronic plc, Olympus Corporation, - EIN News
Positive Trial Data on Evolut TAVR Likely to Support MDT Stock - Yahoo Finance
Disposable Medical Sensors Market Projected To Witness Substantial Growth, 2025-2032: Medtronic Plc, GE - EIN News
Medtronic's SMART trial shows positive Evolut TAVR performance in small aortic annulus patients - Mass Device
Medtronic announces two-year trial outcomes of Evolut TAVR - Yahoo Finance
Is Medtronic plc (MDT) the Best Performing Dividend Stock to Buy Now? - Insider Monkey
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients - Medtronic
Portable Medical Devices Market is Booming Worldwide | Medtronic, Philips, GE Healthcare - openPR
14 Best Performing Dividend Stocks To Buy Now - Insider Monkey
Is Medtronic Stock Underperforming the Nasdaq? - MSN
Medtronic (NYSE:MDT) Approves US$0.70 Cash Dividend for Q4 2025 - Yahoo Finance UK
LGT Group Foundation Sells 9,762 Shares of Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic Maintains Quarterly Dividend at $0.70 Per Share, Payable April 11 to Shareholders of Record on March 28 - Marketscreener.com
Medtronic announces cash dividend for fourth quarter of fiscal year 2025 - Medtronic
Can Medtronic's 47-Year Dividend Growth Streak Signal Long-Term Value? - StockTitan
Medtronic launches extravascular defibrillator in Japan - Mass Device
Smart Home Healthcare Market Set to Witness Significant Growth by 2025-2032: Medtronic PLC, Sleepace, Evermind - EIN News
Is Medtronic Stock Underperforming The Nasdaq? - Barchart
Citigroup Upgrades Medtronic (XTRA:2M6) - Nasdaq
Medtronic and Philips Sign MoU to Upskill 300+ Clinicians in Structural Heart Imaging Pan India - Elets
Medtronic (MDT) Shares Cross 3% Yield Mark - Nasdaq
Is Medtronic plc (MDT) the Best Dividend Stock to Buy According to Billionaires? - Insider Monkey
Medtronic Launches Bold 10-Year Global Initiative To Propel 1M Low-Income Students Into Health Tech Careers - CSRwire.com
This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Analyst Expectations For Medtronic's Future - Benzinga
Ambulance Equipment Market Is Booming Worldwide 2025-2032: 3M, BLS Systems Ltd, Medtronic Plc, Allied - EIN News
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):